In summary, our data provide new perspectives on the effect of HAT inhibitors on the epigenome and provide knowledge of the broad domains unique to different histological grades of human pancreatic cancer cell line models. The gene discussed is TMPRSS11D; the disease is pancreatic neoplasm.